Cargando…

Osteoarthritis: Can We Do Better?

Osteoarthritis (OA) is the most common form of arthritis, affecting approximately 32.5 million adults in the United States. OA is characterized as a degenerative joint disease or “wear and tear” arthritis. Symptoms experienced by patients include, but are not limited to, swelling, stiffness, pain or...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Dylon P, Elsouri, Kawther N, Demory Beckler, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750799/
https://www.ncbi.nlm.nih.gov/pubmed/36532910
http://dx.doi.org/10.7759/cureus.31505
_version_ 1784850336810270720
author Collins, Dylon P
Elsouri, Kawther N
Demory Beckler, Michelle
author_facet Collins, Dylon P
Elsouri, Kawther N
Demory Beckler, Michelle
author_sort Collins, Dylon P
collection PubMed
description Osteoarthritis (OA) is the most common form of arthritis, affecting approximately 32.5 million adults in the United States. OA is characterized as a degenerative joint disease or “wear and tear” arthritis. Symptoms experienced by patients include, but are not limited to, swelling, stiffness, pain or aching, and decreased range of motion. The majority of individuals impacted by OA are over the age of 65. OA has long been thought of as an inevitable part of aging. Patients are typically diagnosed after the onset of symptoms once irreversible damage has occurred, such as the breakdown of bone and cartilage. Along with clinical presentations, medical professionals often relied on radiographic images to confirm the diagnosis of OA. Limited research has looked into how to catch OA early and stage patients in a pre-OA state, possibly preventing irreparable damage that is observable radiographically. This article presents the history, diagnosis, and classes of OA. In addition, we present multiple diagnostic tools currently used and others under investigation, including OA-specific biomarkers and electroarthrography (EAG). These tools show promise as aids in early OA diagnosis and intervention, ultimately slowing down or altogether stopping the progression of OA. In conjunction or individually, these techniques, if further developed, stand out as promising mechanisms that may decrease the current OA burden on the healthcare system.
format Online
Article
Text
id pubmed-9750799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97507992022-12-15 Osteoarthritis: Can We Do Better? Collins, Dylon P Elsouri, Kawther N Demory Beckler, Michelle Cureus Rheumatology Osteoarthritis (OA) is the most common form of arthritis, affecting approximately 32.5 million adults in the United States. OA is characterized as a degenerative joint disease or “wear and tear” arthritis. Symptoms experienced by patients include, but are not limited to, swelling, stiffness, pain or aching, and decreased range of motion. The majority of individuals impacted by OA are over the age of 65. OA has long been thought of as an inevitable part of aging. Patients are typically diagnosed after the onset of symptoms once irreversible damage has occurred, such as the breakdown of bone and cartilage. Along with clinical presentations, medical professionals often relied on radiographic images to confirm the diagnosis of OA. Limited research has looked into how to catch OA early and stage patients in a pre-OA state, possibly preventing irreparable damage that is observable radiographically. This article presents the history, diagnosis, and classes of OA. In addition, we present multiple diagnostic tools currently used and others under investigation, including OA-specific biomarkers and electroarthrography (EAG). These tools show promise as aids in early OA diagnosis and intervention, ultimately slowing down or altogether stopping the progression of OA. In conjunction or individually, these techniques, if further developed, stand out as promising mechanisms that may decrease the current OA burden on the healthcare system. Cureus 2022-11-14 /pmc/articles/PMC9750799/ /pubmed/36532910 http://dx.doi.org/10.7759/cureus.31505 Text en Copyright © 2022, Collins et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Rheumatology
Collins, Dylon P
Elsouri, Kawther N
Demory Beckler, Michelle
Osteoarthritis: Can We Do Better?
title Osteoarthritis: Can We Do Better?
title_full Osteoarthritis: Can We Do Better?
title_fullStr Osteoarthritis: Can We Do Better?
title_full_unstemmed Osteoarthritis: Can We Do Better?
title_short Osteoarthritis: Can We Do Better?
title_sort osteoarthritis: can we do better?
topic Rheumatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750799/
https://www.ncbi.nlm.nih.gov/pubmed/36532910
http://dx.doi.org/10.7759/cureus.31505
work_keys_str_mv AT collinsdylonp osteoarthritiscanwedobetter
AT elsourikawthern osteoarthritiscanwedobetter
AT demorybecklermichelle osteoarthritiscanwedobetter